Results

Total Results: 1,631 records

Showing results for "cancer".
Users also searched for: colon cancer screening

1. Cancer-Drugs-Utilization Research (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization_research.pdf
   January 01, 2011 - malignancies and/ or head and neck cancer (an off- label use). … indicative of its use in malignant neoplasms of the genitourinary tract (e.g., bladder cancer). … both malignant neoplasm of pancreas (157) and esophagus (150), appeared in 23 percent of beneficiaries … Sixty-seven percent of beneficiaries with an imatinib order had a prior diagnosis of malignant neoplasm … Denileukin was accompanied by a prior diagnosis of malignant neoplasm of lymphatic and hematopoietic

2. Disparities and Barriers for Pediatric Cancer Survivorship Care | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/pediatric-cancer-survivorship/protocol
   June 24, 2020 - kidney failure, liver disease, osteopenia and osteoporosis, neurocognitive deficits, and secondary malignancies … for CCS is critical to minimize and alleviate disparities due to the adverse sequelae of their prior malignancy … *” OR “oncolog*” OR “neoplasm” OR “neoplasms” OR “tumor” OR “tumors” OR “cancer” OR “cancers” OR “malignan … *” OR “oncolog*” OR “neoplasm” OR “neoplasms” OR “tumor” OR “tumors” OR “cancer” OR “cancers” OR “malignan … *” OR “oncolog*” OR “neoplasm” OR “neoplasms” OR “tumor” OR “tumors” OR “cancer” OR “cancers” OR “malignan

3. head-neck-cancer-update-140204 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/head-neck-cancer-update_research-protocol.pdf
   February 04, 2014 - Cancer Network.2 The consensus definition of head and neck cancer includes tumors of: • larynx; … cancer; • esophageal cancer; and • trachea tumors. … [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR tumour [TIAB] OR tumours [TIAB] OR cancer [TIAB] OR cancers … "[Mesh] OR (("Neoplasms"[Mesh] OR neoplasms [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR tumour [TIAB … "[Mesh] OR (("Neoplasms"[Mesh] OR neoplasms [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR tumour [

4. Renal-Cancer Research-Protocol (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_research-protocol.pdf
   April 20, 2015 - early-stage cancers, the death rate from kidney cancer has not changed significantly over the same … in the range of 0.55 to 0.65.[3, 16- 18] The best predictors of malignancy are male sex and tumor size … – who have the highest risk of having aggressive malignancies. … Given the increased incidence in early, low-stage tumors without improvement in cancer-related deaths … Frank, I., et al., Independent validation of the 2002 American Joint Committee on cancer primary tumor

5. Radiotherapy Treatments for Head and Neck Cancer: Update | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/head-neck-cancer-update/research-protocol
   February 04, 2014 - tumors otologic tumors cutaneous tumors of the head and neck (including melanoma) thyroid cancer … parathyroid cancer esophageal cancer trachea tumors All therapeutic strategies will be included … OR (("Neoplasms"[Mesh] OR neoplasms [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR tumour [TIAB] OR tumours … "[Mesh] OR (("Neoplasms"[Mesh] OR neoplasms [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR tumour [TIAB … "[Mesh] OR (("Neoplasms"[Mesh] OR neoplasms [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR tumour [TIAB

6. Data Points #7: Utilization of anticancer biologic products among Medicare beneficiaries, by diagnostic cancer subchapter, 2006-2009 | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/cancer-drugs-utilization/research
   August 26, 2011 - Points #7: Utilization of anticancer biologic products among Medicare beneficiaries, by diagnostic cancer … malignancies and/or head and neck cancer (an off-label use). … indicative of its use in malignant neoplasms of the genitourinary tract (e.g., bladder cancer). … to the National Comprehensive Cancer Network. … Such use is not uncommon in cancer patients who have failed more traditional treatments.

7. Renal-Cancer Executive (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/renal-cancer_executive.pdf
   February 01, 2016 - Given the increased incidence in early, low-stage tumors without improvement in cancer-related deaths … Tumor Characteristics 9 Low Increasing RENAL nephrometry score is consistently associated with malignancy … Importantly, cancer-specific survival was associated with tumor size/stage, but not partial or radical … However, differences in cancer-specific survival among modalities is likely unrelated to age or tumor … Current composite models do not reliably predict malignancy; however, tumor size and male sex are most

8. skin-cancer-protocol-160810 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-cancer_research-protocol.pdf
   August 10, 2016 - ) and squamous cell carcinoma (SCC), are the most common malignancies in the U.S.1 BCC and SCC are collectively … Cancer Council Australia and Australian Cancer Network. 2008. 26. … or "Oropharyngeal Neoplasms"[Mesh] OR Pharynx OR Pharyngeal neoplasms OR "Pharyngeal Neoplasms"[Mesh … ] or "Lung Neoplasms"[Mesh] or "Urinary Bladder Neoplasms"[Mesh] or "Uterine Cervical Neoplasms"[Mesh … ] or "Esophageal Neoplasms"[Mesh] or "Laryngeal Neoplasms"[Mesh])) AND (((Surger* or surgic*) and

9. Comparative Effectiveness of Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment–An Update to the 2006 Report | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/cancer-anemia-update/research-protocol
   June 16, 2010 - The prevalence of anemia varies according to the type of neoplasia. 7 Patients with hematological malignancies … versus hematological malignancies versus mixed (studies including both solid tumors and hematological … * OR tumor OR tumors OR tumour* OR neoplas* OR carcinom* #59 Search erythropoietin OR epoetin* OR … AND ("Neoplasms"[Mesh] OR "Carcinoma"[Mesh] OR malignan* OR cancer OR cancers OR cancerous OR oncolog … * OR myelodysplas* OR tumor OR tumors OR tumour* OR neoplas* OR carcinom*) AND ("adverse effects

10. Radiotherapy-Proton-Beam Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiotherapy-proton-beam_research.pdf
    May 01, 2012 - analysis included all Medicare ben- eficiaries with claims indicating a diagno- sis in the malignant or benign … neoplasms range of the ICD-9 codes (140-239) and receipt of proton beam therapy (HCPCS 77520-77525 … cancers (Table 7). … Typically a prostate cancer case will have this daily charge 30 times, and ocular tumor 5 times. … fur- ther multiplied by the fact that with 6 to 8 weeks of therapy (compared to one week for ocular neoplasms

11. Cancer-Pancreas Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-pancreas_research-protocol.pdf
    August 09, 2013 - Studies that report data by tumor (e.g., percentage of pancreatic adenocarcinoma tumors that were correctly … Diagnostic management of pancreatic cancer. Cancers. 2011 Mar;3(1):494-509. 5. … exp pancreas, exocrine/) and (neoplasm/ or adenocarcinoma/ or neoplasms/)) or pancreas tumor/ or Pancreatic … r$ or sarcoma$ or neoplasm$ or carcinoma$ or adenocarcinoma$)).mp. 4 neuroendocrine tumors/ and … and imaging and diagnosis 17 and 23 25 Staging Cancer staging/ or Neoplasm staging/ 26 ((mass

12. Evidence-based Practice Center Technical Brief Protocol: Disparities and Barriers for Pediatric Cancer Survivorship Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/pediatric-cancer-survivorship-protocol.pdf
    June 01, 2020 - kidney failure, liver disease, osteopenia and osteoporosis, neurocognitive deficits, and secondary malignancies … for CCS is critical to minimize and alleviate disparities due to the adverse sequelae of their prior malignancy … *” OR “oncolog*” OR “neoplasm” OR “neoplasms” OR “tumor” OR “tumors” OR “cancer” OR “cancers” OR “malignan … *” OR “oncolog*” OR “neoplasm” OR “neoplasms” OR “tumor” OR “tumors” OR “cancer” OR “cancers” OR “malignan … *” OR “oncolog*” OR “neoplasm” OR “neoplasms” OR “tumor” OR “tumors” OR “cancer” OR “cancers” OR “malignan

13. Prostate-Cancer-Test Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-test_research-protocol.pdf
    October 14, 2011 - (particularly cancerous tumors with aggressive features)? … Indolent Cancers of the Prostate (Key Question 3) Figure 2. … ] (OR text words “prostate cancer”, “prostatic cancer”, “prostate neoplasms”, “prostatic neoplasms” … Characteristics  Age  Race  Benign prostatic hyperplasia  High-grade prostatic intraepithelial neoplasia … "[Mesh] OR "prostatic neoplasms" OR "prostate neoplasms" OR "prostatic cancer" OR "prostate cancer"

14. Therapies for Clinically Localized Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies/protocol
    September 12, 2019 - non-dermatologic malignancy (174,650 new cases) and the second leading cause of cancer death (31,620 … With AS, tumors are not immediately removed, irradiated, or ablated. 3 , 4 Instead, tumors are monitored … Stage 1 T2= tumor Stage 2 T3= tumor Stage 3 T4= tumor Stage 4 WMD= weighted mean differences … / (121506) 2     (prostat* and (neoplasm* or cancer* or carcinoma*)).ti,ab. (142514) 3     watchful … / (9241) 2     (prostat$.ti,ab. or Prostate/) and (cancer.ti,ab. or Neoplasms/ or neoplasm$.mp. or

15. PCA3 Testing for the Diagnosis and Management of Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/prostate-cancer-test/research-protocol
    October 14, 2011 - (particularly cancerous tumors with aggressive features)? … Indolent Cancers of the Prostate (Key Question 3) Figure 2. Analytic framework for KQ 3. … OR text words “prostate cancer”, “prostatic cancer”, “prostate neoplasms”, “prostatic neoplasms”) AND … Characteristics Age Race Benign prostatic hyperplasia High-grade prostatic intraepithelial neoplasia … "[Mesh] OR "prostatic neoplasms" OR "prostate neoplasms" OR "prostatic cancer" OR "prostate cancer"

16. Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/renal-cancer/clinician
    July 18, 2017 - Renal cell carcinoma accounts for more than 94 percent of kidney malignancies. … treatment for patients with clinical stage T1a tumors (≤4 cm in diameter) and T1b tumors (4–7 cm) and … Tumor size and male sex are the factors that are statistically significantly associated with malignancy … Tumor Size 12 (9,401) A positive relationship between tumor size and malignancy risk was found. … score b and malignancy risk was found.

17. Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/cancer-pancreas/research-protocol
    August 09, 2013 - Diagnostic management of pancreatic cancer. Cancers. 2011 Mar;3(1):494-509. … Pancreatic, neuroendocrine GI, and adrenal cancers. … / or exp pancreas, exocrine/) and (neoplasm/ or adenocarcinoma/ or neoplasms/)) or pancreas tumor … r$ or sarcoma$ or neoplasm$ or carcinoma$ or adenocarcinoma$)).mp. 4   neuroendocrine tumors … and imaging and diagnosis 17 and 23 25 Staging Cancer staging/ or Neoplasm staging/ 26  

18. Organisation (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-radiation_appendixes.pdf
    June 16, 2008 - Clinical study of proton radiotherapy in urological cancers [Japanese]. … Proton therapy for head and neck malignancies at Tsukuba. … Cancer Journal 2006 Apr;12(2):155-9. 16630407 No malignancy Makarova GV, Matveev BP, Leonova NS, … [Use of high energy protons in the combination treatment of cervix neoplasms] [Russian]. … Uveal lymphoid neoplasia: a clinical-pathologic correlation and review of the early form.

19. Cancer-Pancreas Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-pancreas_executive.pdf
    September 01, 2014 - Studies that reported data by tumor (e.g., x percent of pancreatic adenocarcinoma tumors were correctly … imaging and pathology that showed a benign lesion, e.g., branch duct intraductal papillary mucinous neoplasia … Diagnostic management of pancreatic cancer. Cancers. 2011 Mar;3(1):494-509. 5. … Pancreatic, neuroendocrine GI, and adrenal cancers. … compared with Fluorodeoxyglucose positron emission tomography/computed tomography for pancreatic malignancy

20. Treatment of Stage I-III Squamous Cell Anal Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/anal-cancer-protocol.pdf
    September 26, 2023 - Background Although anal cancer only represents1-2 percent of all gastrointestinal malignancies, incidence … iliac nodes), M0 III T3-T4 (tumor >5cm in greatest dimension or tumor of any size invading … A., & American Joint Committee on Cancer Expert Panel on Cancers of the Lower Gastrointestinal, Anus … ti,ab. 28776 22 10 Neoplasm grading/ or Neoplasm Invasiveness/ or Neoplasm Metastasis/ or … Neoplasm Recurrence, Local/ or Recurrence/ or neoplasm staging/ or Tumor Burden/ or ((neoplasm?